New rapid test aims to spot COVID, flu, and RSV in minutes
NCT ID NCT05268939
First seen Jun 19, 2026 · Last updated Jun 19, 2026
Summary
This study tested two new rapid swab tests that can detect COVID-19, influenza A/B, and RSV from a single sample. Researchers enrolled 589 people with symptoms and compared the test results to standard lab methods. The goal was to see how accurate and easy the tests are to use at clinics and other point-of-care sites.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Benchmark Research
Covington, Louisiana, 70433, United States
-
Clinical Research Solutions
Middleburg Heights, Ohio, 44130, United States
-
Cullman Clinical Trials
Cullman, Alabama, 35055, United States
-
Diagnamics, Inc
Encinitas, California, 92024, United States
-
Excellence Medical and Research
Miami Gardens, Florida, 33169, United States
-
Koch Family Medicine
Morton, Illinois, 61550, United States
-
Machuca Foundation
Las Vegas, Nevada, 89104, United States
-
Marisela Gonzalez, MD, PA
Miami, Florida, 33155, United States
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
LumiraDx SARS-CoV-2 & Flu A/B test and LumiraDx SARS-CoV-2 & RSV test (diagnostic swab tests)
What this could lead to
If successful, these tests could allow healthcare workers to quickly and accurately diagnose COVID-19, flu, or RSV at the point of care, helping guide treatment decisions.
What could go wrong
This is a completed study evaluating test accuracy, not a treatment. The tests may not be as accurate as lab-based methods, and results depend on proper sample collection and timing.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.